Meibomian gland dysfunction


Also found in: Acronyms.

Meibomian gland dysfunction

A chronic eye disorder caused by Meibomian gland obstruction, resulting in reduced lipids in tears and rapid evaporation of tears, leading to dry eye.

Management
Ranges from lid margin hygiene, warming, massage and artificial tears in banal cases, to tetracyclines and topical steroids in severe cases.
References in periodicals archive ?
Comparison of the efficacy of topical N-acetyl-cysteine and a topical steroid-antibiotic combination therapy in the treatment of meibomian gland dysfunction.
and abroad to eye physicians on different aspects of cataract, corneal, and refractive surgery as well as dry eye and meibomian gland dysfunction.
A New System, the LipiFlow, for the Treatment of Meibomian Gland Dysfunction (MGD)," which will be published in the April 2012 issue of Cornea (31:396-404), was co-authored by Stephen S.
Of those, the majority suffer from meibomian gland dysfunction (MGD).
Of the more than 100 million dry eye sufferers worldwide, approximately 65 percent have evaporative dry eye, which is often caused by meibomian gland dysfunction (MGD) and a lipid deficiency of the eye's natural tear film.
Evaporative dry eye is caused by a deficiency in the lipid layer of the eye's natural tear film, resulting from blockages in the lipid-producing meibomian glands located in the eyelids, called meibomian gland dysfunction.
The meibomian gland dysfunction (MGD) report (2011) further reviewed and defined the significant role for MGD in over 80% of dry eye diagnoses.
Nichols has served as principal investigator or participated in numerous industry-sponsored studies in dry eye and Meibomian Gland Dysfunction (MGD), and recently served as the chair of the International Workshop on MGD.
The product, launched in 2007, has a patent pending for its potential adjuvant use in meibomian gland dysfunction.
TearScience's advanced solutions are designed to help eye care physicians treat patients suffering from evaporative dry eye disease and Meibomian Gland Dysfunction.
A second, larger trial will focus on patients with meibomian gland dysfunction.
As a preservative-free oil-in-water emulsion, Retaine MGD(TM) will target individuals suffering from Meibomian Gland Dysfunction, a component of Dry Eye Syndrome.